Azelastine Hydrochloride; Fluticasone Propionate Patent Expiration
Azelastine Hydrochloride; Fluticasone Propionate is Used for relieving symptoms of seasonal allergic rhinitis. It was first introduced by Mylan Specialty Lp
Azelastine Hydrochloride; Fluticasone Propionate Patents
Given below is the list of patents protecting Azelastine Hydrochloride; Fluticasone Propionate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Dymista |
US8168620 (Pediatric) | Combination of azelastine and steroids | Aug 24, 2026 | Mylan Speciality Lp |
| Dymista | US8168620 | Combination of azelastine and steroids | Feb 24, 2026 | Mylan Speciality Lp |
| Dymista |
US8163723 (Pediatric) | Combination of azelastine and steroids |
Feb 29, 2024
(Expired) | Mylan Speciality Lp |
| Dymista |
US9259428 (Pediatric) | Combination of azelastine and fluticasone for nasal administration |
Dec 13, 2023
(Expired) | Mylan Speciality Lp |
| Dymista | US8163723 | Combination of azelastine and steroids |
Aug 29, 2023
(Expired) | Mylan Speciality Lp |
| Dymista | US9259428 | Combination of azelastine and fluticasone for nasal administration |
Jun 13, 2023
(Expired) | Mylan Speciality Lp |
| Dymista | US9901585 | Combination of azelastine and fluticasone for nasal administration |
Jun 13, 2023
(Expired) | Mylan Speciality Lp |
Azelastine Hydrochloride; Fluticasone Propionate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List